New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress

被引:45
|
作者
Ayuso, Maria I. [1 ]
Hernandez-Jimenez, Macarena [1 ]
Martin, Maria E. [1 ]
Salinas, Matilde [1 ]
Alcazar, Alberto [1 ]
机构
[1] Hosp Ramon & Cajal, Dept Invest, E-28034 Madrid, Spain
关键词
SIGNAL-TRANSDUCTION PATHWAYS; MOLECULAR-MECHANISMS; MAMMALIAN TARGET; DOWN-REGULATION; PHAS-I; DEPENDENT PHOSPHORYLATION; 4E-BINDING PROTEIN-1; PHOSPHATASE; 2A; RAPAMYCIN MTOR; (S/T)P SITES;
D O I
10.1074/jbc.M110.135103
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eukaryotic initiation factor (eIF) 4E-binding protein 1 (4E-BP1) is a translational repressor that is characterized by its capacity to bind specifically to eIF4E and inhibit its interaction with eIF4G. Phosphorylation of 4E-BP1 regulates eIF4E availability, and therefore, cap-dependent translation, in cell stress. This study reports a physiological study of 4E-BP1 regulation by phosphorylation using control conditions and a stress-induced translational repression condition, ischemia-reperfusion (IR) stress, in brain tissue. In control conditions, 4E-BP1 was found in four phosphorylation states that were detected by two-dimensional gel electrophoresis and Western blotting, which corresponded to Thr(69)-phosphorylated alone, Thr(69)- and Thr(36)/Thr(45)-phosphorylated, all these plus Ser(64) phosphorylation, and dephosphorylation of the sites analyzed. In control or IR conditions, no Thr(36)/Thr(45) phosphorylation alone was detected without Thr(69) phosphorylation, and neither was Ser(64) phosphorylation without Thr(36)/Thr(45)/Thr(69) phosphorylation detected. Ischemic stress induced 4E-BP1 dephosphorylation at Thr(69), Thr(36)/Thr(45), and Ser(64) residues, with 4E-BP1 remaining phosphorylated at Thr(69) alone or dephosphorylated. In the subsequent reperfusion, 4E-BP1 phosphorylation was induced at Thr(36)/Thr(45) and Ser(64), in addition to Thr(69). Changes in 4E-BP1 phosphorylation after IR were according to those found for Akt and mammalian target of rapamycin (mTOR) kinases. These results demonstrate a new hierarchical phosphorylation for 4E-BP1 regulation in which Thr(69) is phosphorylated first followed by Thr(36)/Thr(45) phosphorylation, and Ser(64) is phosphorylated last. Thr(69) phosphorylation alone allows binding to eIF4E, and subsequent Thr(36)/Thr(45) phosphorylation was sufficient to dissociate 4E-BP1 from eIF4E, which led to eIF4E-4G interaction. These data help to elucidate the physiological role of 4E-BP1 phosphorylation in controlling protein synthesis.
引用
收藏
页码:34355 / 34363
页数:9
相关论文
共 50 条
  • [21] Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E)
    Showkat, Mehvish
    Beigh, Mushtaq A.
    Bhat, Basharat B.
    Batool, Asiya
    Andrabi, Khurshid I.
    CELLULAR SIGNALLING, 2014, 26 (10) : 2117 - 2121
  • [22] Translational Homeostasis via elF4E and 4E-BP1
    Hinnebusch, Alan G.
    MOLECULAR CELL, 2012, 46 (06) : 717 - 719
  • [23] 4E-BP1/eIF4E Cap Dependent Translational Signaling and Regulation in Lung Mesenchymal Cells
    Lama, V. N.
    Walker, N. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
    Maracci, Cristina
    Motta, Stefano
    Romagnoli, Alice
    Costantino, Matteo
    Perego, Paola
    Di Marino, Daniele
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (20) : 3501 - 3529
  • [25] Translational repression by human 4E-BP1 in yeast specifically requires human eIF4E as target
    Hughes, JMX
    Ptushkina, M
    Karim, MM
    Koloteva, N
    von der Haar, T
    McCarthy, JEG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) : 3261 - 3264
  • [26] Hyperphosphorylation of translational repressor 4E-BP1 as prognostic factor in human breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 145 - 145
  • [27] 4E-BP1 and eIF4E in Uveal Melanoma Associate with Prognosis
    Dinares, M. C.
    Parada, C.
    Moline, T.
    Huguet, P.
    Medel, R.
    Veg, P.
    Hernandez-Losa, J.
    MODERN PATHOLOGY, 2010, 23 : 383A - 383A
  • [28] Androgen receptor antagonist bicalutamide sensitizes androgen-independent prostate cancer cells to mTOR inhibitor rapamycin by regulating phosphorylation of translation initiation suppressor eIF4E-binding protein 1 (4E-BP1)
    Bose, Swagata
    Wang, Yu
    Siddiqui, Salma
    Mooso, Benjamin
    Vinall, Ruth
    Tepper, Clifford
    White, Ralph W. deVere
    Mudryj, Maria
    Ghosh, Paramita M.
    CANCER RESEARCH, 2010, 70
  • [29] The Translational Repressor 4E-BP1 Contributes to Diabetes-Induced Visual Dysfunction
    Miller, William P.
    Mihailescu, Maria L.
    Yang, Chen
    Barber, Alistair J.
    Kimball, Scot R.
    Jefferson, Leonard S.
    Dennis, Michael D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (03) : 1327 - 1337
  • [30] Translational control of cell fate: Availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency
    Li, SN
    Sonenberg, N
    Gingras, AC
    Peterson, M
    Avdulov, S
    Polunovsky, VA
    Bitterman, PB
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) : 2853 - 2861